¥3,990.00
0.37%
Tokyo, Sep 18, 03:16 pm JST. Closed.
ISIN
JP3207000005
Symbol
4521

Kaken Pharmaceutical Co Stock price

¥3,980.00
-50.00 1.24% 1M
-315.00 7.33% 6M
-35.00 0.87% YTD
+135.00 3.51% 1Y
+379.31 10.53% 3Y
-846.34 17.54% 5Y
-2,098.71 34.53% 10Y
+2,388.05 150.01% 20Y
Tokyo, Closing price Fri, Sep 18 2026
-25.00 0.62%
ISIN
JP3207000005
Symbol
4521
Industry

Is Kaken Pharmaceutical Co a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
¥144.3b
Enterprise Value
¥90.0b
Net debt
positive
Cash
¥58.1b
Shares outstanding
37.9m
Valuation (TTM | estimate)
P/E
14.6
P/S
1.6 | 1.6
EV/Sales
1.0 | 1.0
EV/FCF
-
P/B
0.9
Dividends
DPS
¥190.00
Yield 1Y | 5Y
4.8% | 4.3%
Growth 1Y | 5Y
0.0% | 5.1%
Payout 1Y | 3Y
336.0% | 83.3%
Increased
0 Years
Financials (TTM | estimate)
Revenue
¥88.2b | ¥91.5b
EBITDA
-
EBIT
¥10.0b
Net Income
¥10.3b
Free Cash Flow
-
Growth (TTM | estimate)
Revenue
-6.9% | 19.0%
EBITDA
-
EBIT
-45.4%
Net Income
-17.3%
Free Cash Flow
-
Margin
Gross
58.0%
EBITDA
-
EBIT
11.3%
Net
11.7%
Free Cash Flow
-
Financial Health
Equity Ratio
82.8%
Return on Equity
1.5%
ROCE
6.1%
ROIC
7.2%
Debt/Equity
0.0
More
EPS
¥272.3
FCF per Share
-
Short interest
-
Employees
1k
Rev per Employee
¥68.3m

Kaken Pharmaceutical Co Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Kaken Pharmaceutical Co forecast:

4x Buy
50%
4x Hold
50%

Analyst Opinions

8 Analysts have issued a Kaken Pharmaceutical Co forecast:

Buy
50%
Hold
50%

Financial data from Kaken Pharmaceutical Co

Jun '26
+/-
%
88,158 88,158
7% 7%
100%
- Direct Costs 37,067 37,067
2% 2%
42%
51,091 51,091
12% 12%
58%
- Selling and Administrative Expenses 21,298 21,298
12% 12%
24%
- Research and Development Expense 19,802 19,802
6% 6%
22%
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 9,989 9,989
45% 45%
11%
Net Profit 10,312 10,312
17% 17%
12%

In millions JPY.

Don't miss a Thing! We will send you all news about Kaken Pharmaceutical Co directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Kaken Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products, medical devices, agrochemicals, and animal health products in Japan. The company is headquartered in Bunkyo-Ku, Tokyo-To and currently employs 1,126 full-time employees. The firm has two business segments. The Pharmaceutical Business segment is primarily engaged in the manufacture and sale of pharmaceuticals, medical equipment, and agricultural chemicals. The Real Estate Business segment is primarily engaged in the rental of real estate related to Bunkyo Green Court.

Head office Japan
Employees 1,126
Website www.kaken.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today